All research
2026-07-15 PubMed

Hlyc41 disrupts SARS-CoV-2 NSP12 hijacking of Hsc70, promoting degradation and suppressing viral replication

Insights into SARS-CoV-2 replication control via targeting the host hijacking function of NSP12.

Background

The SARS-CoV-2 pandemic highlighted an urgent need for effective antiviral therapeutics. A key target is nonstructural protein 12 (NSP12), the RNA-dependent RNA polymerase (RdRp), which forms the catalytic core of the viral replication-transcription complex and is essential for viral RNA synthesis. While NSP12's role is critical, the precise mechanisms governing its intracellular stability, which are vital for efficient viral replication, have remained poorly understood. Understanding these regulatory pathways could reveal novel vulnerabilities for antiviral intervention.

Study Design

Researchers investigated the stability mechanisms of SARS-CoV-2 nonstructural protein 12 (NSP12), the viral RdRp. They identified a previously unrecognized viral strategy where NSP12 hijacks the host chaperone Hsc70 to modulate its own stability. Through mechanistic studies, they elucidated Hsc70's dual role: mediating NSP12 degradation via chaperone-mediated autophagy (CMA) while also promoting its accumulation. They then identified Hlyc41 as a potential antiviral agent by screening for compounds that disrupt this specific NSP12-Hsc70 interaction.

Results

The study revealed that host chaperone Hsc70 plays a dual role in regulating NSP12 levels, both mediating its degradation through chaperone-mediated autophagy (CMA) and promoting its accumulation. The dynamic balance between these opposing functions determines NSP12 fate. Crucially, NSP12 can evade CMA-mediated degradation by binding to Hsc70 with a higher affinity. This strong binding disrupts the normal Hsc70-LAMP2a interaction, shifting Hsc70's primary role towards facilitating NSP12 accumulation, which in turn enhances viral replication. This mechanism represents a novel host hijacking strategy. > Hlyc41 was identified as a potential antiviral agent that effectively disrupts this hijacking mechanism by competing with NSP12 for binding to the F428 residue of Hsc70. This competition promotes NSP12 degradation and consequently suppresses viral replication.

Key Findings

  • SARS-CoV-2 NSP12 hijacks host chaperone Hsc70 to modulate its own stability.
  • Hsc70 has a dual role: mediating NSP12 degradation via CMA and promoting its accumulation.
  • NSP12 evades CMA by binding Hsc70 with higher affinity, disrupting Hsc70-LAMP2a interaction.
  • This shift in Hsc70's role facilitates NSP12 accumulation, enhancing viral replication.
  • Hlyc41 disrupts NSP12-Hsc70 binding by competing for Hsc70's F428 residue, promoting NSP12 degradation and suppressing viral replication.

Why It Matters

This research uncovers a novel host hijacking mechanism employed by SARS-CoV-2 to regulate the stability of its critical NSP12 polymerase, offering a new target for antiviral development. Targeting the NSP12-Hsc70 interaction with compounds like Hlyc41 could provide a distinct therapeutic strategy, potentially overcoming resistance to existing antivirals that target other viral proteins. This approach focuses on disrupting a viral evasion tactic rather than directly inhibiting the polymerase, which might offer a broader therapeutic window or synergistic effects. While Hlyc41 is currently a discovery compound, this finding paves the way for developing new small-molecule inhibitors that interfere with host-pathogen interactions, moving towards a usable protocol for future viral outbreaks.


sars-cov-2 nsp12 hsc70 antiviral viral-replication chaperone-mediated-autophagy
Source: pubmed:42453420 · Ingested 2026-07-15 · Digest: gemini-2.5-flash